1951 — Jinxin Fertility Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapContrarian

Annual income statement for Jinxin Fertility, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	HKAS	HKAS	HKAS	HKAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,648	1,426	1,839	2,364	2,789
Cost of Revenue
Gross Profit	817	566	771	874	1,175
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,091	1,064	1,350	2,134	2,250
Operating Profit	557	363	489	231	539
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	548	349	458	154	464
Provision for Income Taxes
Net Income After Taxes	421	260	354	118	347
Minority Interest
Net Income Before Extraordinary Items
Net Income	410	252	340	121	345
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	410	252	340	126	335
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.208	0.1	0.136	0.057	0.131
Dividends per Share